Shyam Natarajan

Title(s)Assistant Adjunct Professor, Urology
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Assistant Adjunct Professor, Surgery


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prediction and Mapping of Intraprostatic Tumor Extent with Artificial Intelligence. Eur Urol Open Sci. 2023 Aug; 54:20-27. Priester A, Fan RE, Shubert J, Rusu M, Vesal S, Shao W, Khandwala YS, Marks LS, Natarajan S, Sonn GA. PMID: 37545845; PMCID: PMC10403686.
      View in: PubMed   Mentions:
    2. Domain generalization for prostate segmentation in transrectal ultrasound images: A multi-center study. Med Image Anal. 2022 11; 82:102620. Vesal S, Gayo I, Bhattacharya I, Natarajan S, Marks LS, Barratt DC, Fan RE, Hu Y, Sonn GA, Rusu M. PMID: 36148705; PMCID: PMC10161676.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Interstitial Optical Monitoring of Focal Laser Ablation. IEEE Trans Biomed Eng. 2022 08; 69(8):2545-2556. Geoghegan R, Zhang L, Priester A, Wu HH, Marks L, Natarajan S. PMID: 35148260; PMCID: PMC9371599.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    4. Methods of monitoring thermal ablation of soft tissue tumors - A comprehensive review. Med Phys. 2022 Feb; 49(2):769-791. Geoghegan R, Ter Haar G, Nightingale K, Marks L, Natarajan S. PMID: 34965307.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    5. Focal Laser Ablation of Prostate Cancer: An Office Procedure. J Vis Exp. 2021 03 30; (169). Brisbane WG, Natarajan S, Priester A, Felker ER, Kinnaird A, Marks LS. PMID: 33871450.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. Eur Urol. 2021 04; 79(4):456-465. Salami SS, Tosoian JJ, Nallandhighal S, Jones TA, Brockman S, Elkhoury FF, Bazzi S, Plouffe KR, Siddiqui J, Liu CJ, Kunju LP, Morgan TM, Natarajan S, Boonstra PS, Sumida L, Tomlins SA, Udager AM, Sisk AE, Marks LS, Palapattu GS. PMID: 32631746; PMCID: PMC7779657.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Monitoring Focal Laser Ablation with Interstitial Fluence Probes: Monte Carlo Simulation and Phantom Validation. Annu Int Conf IEEE Eng Med Biol Soc. 2020 07; 2020:5272-5275. Geoghegan R, Priester A, Zhang L, Wu H, Marks L, Natarajan S. PMID: 33019173.
      View in: PubMed   Mentions:    Fields:    
    8. Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men. Letter. J Urol. 2021 06; 205(6):1843. Marks LS, Natarajan S. PMID: 32364836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions. Urol Oncol. 2020 07; 38(7):637.e9-637.e15. Al Hussein Al Awamlh B, Marks LS, Sonn GA, Natarajan S, Fan RE, Gross MD, Mauer E, Banerjee S, Hectors S, Carlsson S, Margolis DJ, Hu JC. PMID: 32307327; PMCID: PMC7328785.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    10. Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation. Urology. 2020 04; 138:98-105. Al Hussein Al Awamlh B, Margolis DJ, Gross MD, Natarajan S, Priester A, Hectors S, Ma X, Mosquera JM, Liao J, Hu JC. PMID: 31954170.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Using spatial tracking with magnetic resonance imaging/ultrasound-guided biopsy to identify unilateral prostate cancer. BJU Int. 2020 03; 125(3):399-406. Zhou SR, Priester AM, Jayadevan R, Johnson DC, Yang JJ, Ballon J, Natarajan S, Marks LS. PMID: 31680423; PMCID: PMC7444382.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men. J Urol. 2020 04; 203(4):699-705. Zhou SR, Chang E, Patankar A, Huang J, Marks LS, Natarajan S. PMID: 31596671; PMCID: PMC7384745.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Comparison of Targeted vs Systematic Prostate Biopsy in Men Who Are Biopsy Naive: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. JAMA Surg. 2019 09 01; 154(9):811-818. Elkhoury FF, Felker ER, Kwan L, Sisk AE, Delfin M, Natarajan S, Marks LS. PMID: 31188412; PMCID: PMC6563598.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    14. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Cancer. 2019 09 01; 125(17):2955-2964. Johnson DC, Yang JJ, Kwan L, Barsa DE, Mirak SA, Pooli A, Sadun T, Jayadevan R, Zhou S, Priester AM, Natarajan S, Bajgiran AM, Shakeri S, Sisk A, Felker ER, Raman SS, Marks LS, Reiter RE. PMID: 31042322; PMCID: PMC7368458.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research. J Magn Reson Imaging. 2019 01; 49(1):270-279. Wu HH, Priester A, Khoshnoodi P, Zhang Z, Shakeri S, Afshari Mirak S, Asvadi NH, Ahuja P, Sung K, Natarajan S, Sisk A, Reiter R, Raman S, Enzmann D. PMID: 30069968.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    16. Registration Accuracy of Patient-Specific, Three-Dimensional-Printed Prostate Molds for Correlating Pathology With Magnetic Resonance Imaging. IEEE Trans Biomed Eng. 2019 01; 66(1):14-22. Priester A, Wu H, Khoshnoodi P, Schneider D, Zhang Z, Asvadi NH, Sisk A, Raman S, Reiter R, Grundfest W, Marks LS, Natarajan S. PMID: 29993431; PMCID: PMC6344233.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary? AJR Am J Roentgenol. 2017 Dec; 209(6):1272-1277. Felker ER, Raman SS, Margolis DJ, Lu DSK, Shaheen N, Natarajan S, Sharma D, Huang J, Dorey F, Marks LS. PMID: 28858541; PMCID: PMC5732583.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    18. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy. J Urol. 2018 02; 199(2):453-458. Nassiri N, Chang E, Lieu P, Priester AM, Margolis DJA, Huang J, Reiter RE, Dorey FJ, Marks LS, Natarajan S. PMID: 28830754; PMCID: PMC5780241.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    19. Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer. J Urol. 2018 01; 199(1):98-105. Chang E, Jones TA, Natarajan S, Sharma D, Simopoulos D, Margolis DJ, Huang J, Dorey FJ, Marks LS. PMID: 28728993; PMCID: PMC5760302.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    20. Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance. Urol Case Rep. 2017 Sep; 14:11-14. Simopoulos DN, Natarajan S, Jones TA, Fendler WP, Sisk AE, Marks LS. PMID: 28607878; PMCID: PMC5458645.
      View in: PubMed   Mentions: 11  
    21. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance. J Urol. 2017 10; 198(4):839-847. Natarajan S, Jones TA, Priester AM, Geoghegan R, Lieu P, Delfin M, Felker E, Margolis DJA, Sisk A, Pantuck A, Grundfest W, Marks LS. PMID: 28396184.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    22. Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer. Clin Cancer Res. 2017 Feb 15; 23(4):985-991. Palapattu GS, Salami SS, Cani AK, Hovelson DH, Lazo de la Vega L, Vandenberg KR, Bratley JV, Liu CJ, Kunju LP, Montgomery JS, Morgan TM, Natarajan S, Huang J, Tomlins SA, Marks LS. PMID: 28031426; PMCID: PMC5315613.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    23. Focal Laser Ablation of Prostate Cancer. Urology. 2017 Jan; 99:e21-e22. Jones TA, Natarajan S, Priester AM, Marks LS. PMID: 27720973.
      View in: PubMed   Mentions: 3     Fields:    
    24. Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer. J Urol. 2017 03; 197(3 Pt 1):632-639. Nassiri N, Margolis DJ, Natarajan S, Sharma DS, Huang J, Dorey FJ, Marks LS. PMID: 27639713; PMCID: PMC5315577.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    25. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology. J Urol. 2017 02; 197(2):320-326. Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS. PMID: 27484386; PMCID: PMC5540646.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    26. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Cancer. 2016 Mar 15; 122(6):884-92. Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, Reiter RE, Marks LS. PMID: 26749141; PMCID: PMC4777653.
      View in: PubMed   Mentions: 153     Fields:    Translation:Humans
    27. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. J Urol. 2016 07; 196(1):68-75. Natarajan S, Raman S, Priester AM, Garritano J, Margolis DJ, Lieu P, Macairan ML, Huang J, Grundfest W, Marks LS. PMID: 26748164.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    28. Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value. J Urol. 2016 May; 195(5):1421-1427. Felker ER, Wu J, Natarajan S, Margolis DJ, Raman SS, Huang J, Dorey F, Marks LS. PMID: 26674305; PMCID: PMC4900685.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    29. Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology. Urology. 2015 Sep; 86(3):432-8. Nassiri N, Natarajan S, Margolis DJ, Marks LS. PMID: 26166671; PMCID: PMC4569505.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    30. A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds. Am J Clin Exp Urol. 2014; 2(2):127-35. Priester A, Natarajan S, Le JD, Garritano J, Radosavcev B, Grundfest W, Margolis DJ, Marks LS, Huang J. PMID: 25374914; PMCID: PMC4219304.
      View in: PubMed   Mentions: 21  
    31. Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. Urol Oncol. 2014 Oct; 32(7):952-7. Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. PMID: 25027689; PMCID: PMC4254112.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    32. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. J Urol. 2014 Nov; 192(5):1367-73. Le JD, Stephenson S, Brugger M, Lu DY, Lieu P, Sonn GA, Natarajan S, Dorey FJ, Huang J, Margolis DJ, Reiter RE, Marks LS. PMID: 24793118; PMCID: PMC4201866.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    33. Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? J Urol. 2014 Aug; 192(2):385-90. Hu JC, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Sonn G, Dorey FJ, Marks LS. PMID: 24512956; PMCID: PMC4129939.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    34. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology. 2014 Feb; 83(2):369-75. Chamie K, Sonn GA, Finley DS, Tan N, Margolis DJ, Raman SS, Natarajan S, Huang J, Reiter RE. PMID: 24468511; PMCID: PMC3922632.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    35. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014 Apr; 65(4):809-15. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. PMID: 23523537; PMCID: PMC3858524.
      View in: PubMed   Mentions: 162     Fields:    Translation:Humans
    36. Robotic ultrasound systems in medicine. IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Mar; 60(3):507-23. Priester AM, Natarajan S, Culjat MO. PMID: 23475917.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    37. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol. 2013 Jan; 23(1):43-50. Marks L, Young S, Natarajan S. PMID: 23138468; PMCID: PMC3581822.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    38. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol. 2013 Jan; 189(1):86-91. Sonn GA, Natarajan S, Margolis DJ, MacAiran M, Lieu P, Huang J, Dorey FJ, Marks LS. PMID: 23158413; PMCID: PMC3561472.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    39. Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology. 2012 Jul; 80(1):219-23. Finley DS, Ellingson BM, Natarajan S, Zaw TM, Raman SS, Schulam P, Reiter RE, Margolis D. PMID: 22748877.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    40. A transurethral catheter-based ultrasound system for multi-modal fusion. Stud Health Technol Inform. 2012; 173:463-8. Shkel A, Natarajan S, Schimpf S, Culjat MO, Brose A, Boese A, Schmidt B, Schulam PG, Lee H, Grundfest W, Singh R. PMID: 22357037.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Fine-tuning robot-assisted radical prostatectomy planning with MRI. Urol Oncol. 2013 Aug; 31(6):766-75. Finley DS, Margolis D, Raman SS, Ellingson BM, Natarajan S, Tan N, Huang J, Reiter RE. PMID: 21906964.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol. 2011 May-Jun; 29(3):334-42. Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, Fenster A. PMID: 21555104; PMCID: PMC3432280.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    Shyam's Networks
    Concepts (94)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (17)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California